INTERNATIONAL PATENT: BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD., 百力司康生物医药（杭州）有限公司 FILES APPLICATION FOR "ENGINEERED ANTIBODY WITH SITE-SPECIFIC CONJUGATION, ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF"

GENEVA, May 18 -- BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. (Building 7, Hexiang Technology Center, Qiantang AreaHangzhou, Zhejiang 310018), 百力司康生物医药（杭州）有限公司 (中国浙江省杭州市钱塘区和享科技中心7幢) filed a patent application (PCT/CN2025/133367) for "ENGINEERED ANTIBODY WITH SITE-SPECIFIC CONJUGATION, ANTIBODY-DRUG CONJUGATE, AND APPLICATION THEREOF" on Nov 07, 2025. With publication no. WO/2026/098621, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitt...